Carlo Bifulco
Dr. Bifulco is a board-certified Surgical Pathologist with specialized training in Molecular Genetic Pathology and Hematopathology. He is the Chief Medical Officer at Providence Genomics and leads the Translational Molecular Pathology division at the Earle A. Chiles Research Institute, part of the Providence Cancer Institute in Portland, Oregon. Before his current role, Dr. Bifulco was a faculty member at Yale University's Pathology department and completed fellowships at Memorial Sloan Kettering Cancer Center and Yale. His research focuses on integrating personalized medicine, spatial biology, and AI.”
Abstracts this author is presenting:
